EFFECTS OF ALTERING THE TIME OF ADMINISTRATION AND THE TIME FRAME OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - AN EXAMPLE USING THE EORTC QLQ-C30 IN A LARGE ANTIEMETIC TRIAL
J. Pater et al., EFFECTS OF ALTERING THE TIME OF ADMINISTRATION AND THE TIME FRAME OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - AN EXAMPLE USING THE EORTC QLQ-C30 IN A LARGE ANTIEMETIC TRIAL, Quality of life research, 7(3), 1998, pp. 273-278
Previous studies conducted by our group suggested that the ability to
demonstrate an impact of emesis control on quality of life might depen
d upon when an quality of life instrument was administered in relation
to chemotherapy and on the time frame of the questionnaire. This stud
y was conducted to address this issue. Six hundred and fifty patients
receiving moderately emetogenic chemotherapy in a randomized trial com
paring a variety of anti-emetic regimens were allocated to four differ
ent modes of administration (days 4 and 8; 3 and 7 day time frames) of
the QLQ-C30. Patients who completed the questionnaire at the time of
maximal impact of chemotherapy (day 3) were more likely to report dete
rioration in quality of life. Patients who completed questionnaires at
day 8 were more likely to report deterioration in quality of life if
their questionnaire had a 7 day time frame rather than a 3 day time fr
ame. Patients receiving more effective antiemetic therapy had better q
uality of life. It was concluded that better anti-emetic control impro
ves quality of life after moderately emetogenic chemotherapy. In study
ing quality of life in situations where the impact of treatment waxes
and wanes, careful attention needs to be paid to scheduling the admini
stration of questionnaires and to their time frame. (C) 1998 Lippincot
t-Raven Publishers.